Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Brain metastasis in hypernephroma.

P C Gay, W J Litchy, T L Cascino

    Journal of Neuro-Oncology
    |January 1, 1987
    PubMed
    Summary
    This summary is machine-generated.

    Brain metastasis is a late complication of hypernephroma, affecting 3.9% of patients. This condition is associated with a poor prognosis, especially when diagnosed after initial treatment.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Development of measures of polyneuropathy impairment in hATTR amyloidosis: From NIS to mNIS + 7.

    Journal of the neurological sciences·2019
    Same author

    Meta-analysis of the association between obstructive sleep apnoea and postoperative outcome.

    British journal of anaesthesia·2012
    Same author

    Myelin protein zero mutation His39Pro: hereditary motor and sensory neuropathy with variable onset, hearing loss, restless legs and multiple sclerosis.

    Journal of neurology, neurosurgery, and psychiatry·2006
    Same author

    The gene for HMSN2C maps to 12q23-24: a region of neuromuscular disorders.

    Neurology·2003
    Same author

    Noninvasive proportional assist ventilation for acute respiratory insufficiency. Comparison with pressure support ventilation.

    American journal of respiratory and critical care medicine·2001
    Same author

    Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials.

    Journal of the neurological sciences·2001
    Same journal

    Serum lactate dehydrogenase is associated with the presence and extent of preoperative peritumoral edema in melanoma brain metastases.

    Journal of neuro-oncology·2026
    Same journal

    Feasibility evaluation of tumor treating fields for brainstem gliomas.

    Journal of neuro-oncology·2026
    Same journal

    Intraoperative technological advances and new frontiers in precision glioma surgery.

    Journal of neuro-oncology·2026
    Same journal

    Optimizing the Stupp protocol for treatment of glioblastoma: eliminating age bias, enhancing treatment timing, use of stereotactically-guided sequential boost, and dexamethasone dosing.

    Journal of neuro-oncology·2026
    Same journal

    Gamma knife radiosurgery for renal cell carcinoma brain metastases across systemic therapy eras: survival, intracranial failure, and lesion-level predictors.

    Journal of neuro-oncology·2026
    Same journal

    Real-time confocal imaging for evaluation of dose-dependent effects of gamma knife radiosurgery on U87 glioblastoma cell line.

    Journal of neuro-oncology·2026
    See all related articles

    Area of Science:

    • Oncology
    • Neurology
    • Radiology

    Background:

    • Hypernephroma, also known as renal cell carcinoma, can metastasize to various organs.
    • Brain metastasis from hypernephroma is a significant clinical concern with limited treatment options.

    Purpose of the Study:

    • To investigate the incidence, clinical characteristics, and prognostic implications of brain metastasis in patients with hypernephroma.
    • To compare the survival outcomes of different treatment modalities for brain metastasis.

    Main Methods:

    • Retrospective analysis of 926 patients diagnosed with hypernephroma.
    • Review of patient records, imaging studies (computed tomography), and treatment outcomes.
    • Statistical analysis of survival data based on treatment received (radiation therapy vs. surgery plus radiation).

    Related Experiment Videos

    Main Results:

    • Brain metastasis was identified in 3.9% of hypernephroma patients, typically as a late complication (median interval 65.5 weeks post-diagnosis).
    • Most patients (28%) presented with hyperdense lesions on CT before contrast.
    • Patients treated with surgery and radiation had a significantly longer median survival (66 weeks) compared to those receiving only radiation therapy (13 weeks).

    Conclusions:

    • Brain metastasis is an uncommon but serious late complication of hypernephroma.
    • Surgical resection combined with postoperative radiation therapy may improve survival outcomes.
    • Hypernephroma with brain metastasis generally carries a poor prognosis.